MAIA Biotechnology, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events - Additional Information (Details)

Subsequent Events - Additional Information (Details) - USD ($)						1 Months Ended	3 Months Ended
	May 10, 2024	Apr. 25, 2024	Mar. 28, 2024	Mar. 25, 2024	Mar. 14, 2024	May 14, 2024	Mar. 31, 2024	Feb. 14, 2024	Dec. 31, 2023	Aug. 01, 2022
Subsequent Event [Line Items]
Common stock, par value							$ 0.0001		$ 0.0001
Options outstanding, Granted							984,455
Warrants exercise price, per share			$ 2.55		$ 1.3					$ 6.25
Non-affiliated Investors
Subsequent Event [Line Items]
Warrants to purchase common stock			578,643
Common Stock
Subsequent Event [Line Items]
Warrants to purchase common stock			349,886		1,794,882
Common Stock \| Non-affiliated Investors
Subsequent Event [Line Items]
Warrants to purchase common stock					2,043,587
At The Market Offering Agreement \| H.C. Wainwright and Co., LLC
Subsequent Event [Line Items]
Common stock, par value				$ 0.0001
Percentage of gross proceeds of offerings				3.00%
Number of common stock Issued and sold				748,808
Common stock per share				$ 3.03
Gross proceeds from sale of common stock				$ 2,265,162
At The Market Offering Agreement \| H.C. Wainwright and Co., LLC \| Maximum \| Common Stock
Subsequent Event [Line Items]
Aggregate sales price								$ 1,445,000
Aggregate offering price				$ 4,950,000
At-the-Market Equity Offering \| Common Stock
Subsequent Event [Line Items]
Number of common stock Issued and sold							507,754
Private Placement
Subsequent Event [Line Items]
Common stock per share			$ 2.295		$ 1.17
Aggregate purchase price			$ 1,330,000		$ 2,920,000
Warrants exercise price, per share					$ 1.3
Private Placement \| Stan Smith
Subsequent Event [Line Items]
Number of common stock Issued and sold							170,940
Aggregate purchase price							$ 200,000
Warrants to purchase common stock							170,940
Private Placement \| Louie Ngar Yee
Subsequent Event [Line Items]
Number of common stock Issued and sold							170,940
Aggregate purchase price							$ 200,000
Warrants to purchase common stock							170,940
Private Placement \| Common Stock
Subsequent Event [Line Items]
Number of common stock Issued and sold			578,643		2,496,318
Private Placement \| Investor Warrants
Subsequent Event [Line Items]
Number of common stock Issued and sold			578,643		2,496,318
Common stock per share			$ 2.55		$ 1.3
Subsequent Event
Subsequent Event [Line Items]
Options outstanding, Granted						648,263
Weighted Average Exercise Price, Exercised						$ 2.94
Subsequent Event \| Non-affiliated Investors
Subsequent Event [Line Items]
Warrants to purchase common stock		326,939
Warrants exercise price, per share		$ 2.26
Subsequent Event \| Common Stock
Subsequent Event [Line Items]
Warrants exercise price, per share		263,027
Subsequent Event \| Warrant
Subsequent Event [Line Items]
Number of new stock issued during the period	4,678
Subsequent Event \| Private Placement
Subsequent Event [Line Items]
Common stock per share		$ 2.034
Aggregate purchase price		$ 1
Subsequent Event \| Private Placement \| Stan Smith
Subsequent Event [Line Items]
Number of common stock Issued and sold		147,492
Aggregate purchase price		$ 300,000
Warrants to purchase common stock		147,492
Subsequent Event \| Private Placement \| Louie Ngar Yee
Subsequent Event [Line Items]
Number of common stock Issued and sold		19,665
Aggregate purchase price		$ 40,000
Warrants to purchase common stock		19,665
Subsequent Event \| Private Placement \| Common Stock
Subsequent Event [Line Items]
Number of common stock Issued and sold		494,096
Subsequent Event \| Private Placement \| Investor Warrants
Subsequent Event [Line Items]
Common stock per share		$ 2.26
Subsequent Event \| Private Placement \| Warrant
Subsequent Event [Line Items]
Number of common stock Issued and sold		494,096